In vivo characterisation of tumour metabolism using MRS would facilitate tumour therapy response assessment, but in vivo conditions may obscure the metabolic information acquired. In this study we investigate the information contained in in vivo MRS spectra of a neuroendocrine tumour model by correlating it to ex vivo HR-MAS MRS on excised tumour samples. Effects of post-mortem tissue degradation and tumour sample site on in vivo–ex vivo correlations are evaluated, and interpretation of in vivo data is discussed.
This abstract and the presentation materials are available to members only; a login is required.